Professor Nicholas PJ Day
Podcast interview
Infectious diseases in South East Asia
MORU aims to fight the infectious tropical diseases affecting rural communities in Asia and elsewhere in the developing world. MORU's malaria research aims to directly improve the treatment of the disease globally. It's researchers focus on the treatment of severe malaria, the spread of antimalarial drug resistance, and the pathophysiology of falciparum and vivax malaria. These studies are used to formulate novel adjuvant therapies, and have been translated into recommendations for the use of artemisinin based combination therapies.
Research groups
Colleges
Nicholas Day
MA BM BCh DM FRCP FMedSci
Professor of Tropical Medicine
- Director of the Mahidol Oxford Tropical Medicine Research Unit, Thailand, and of the Wellcome Trust Thailand Asia and Africa Programme
MORU
Nick Day's interests include the epidemiology, diagnosis, pathophysiology, pathogen biology, treatment and prevention of malaria, rickettsial diseases including scrub typhus, melioidosis, leptospirosis, rickettsial infections, influenza, dengue and other communicable diseases afflicting rural populations throughout Asia and beyond. Cross-cutting interests include the drivers and epidemiology of AMR, and the syndromic management of febrile illnesses and sepsis in LMIC settings.
Recent publications
-
Blood transcriptomics to characterize key biological pathways and identify biomarkers for predicting mortality in melioidosis.
Yimthin T. et al, (2021), Emerging microbes & infections, 10, 8 - 18
-
Clustering of malaria in households in the Greater Mekong Subregion: operational implications for reactive case detection.
Mukaka M. et al, (2021), Malaria journal, 20
-
Genetic surveillance in the Greater Mekong subregion and South Asia to support malaria control and elimination
Jacob CG. et al, (2021), eLife, 10
-
Improving statistical power in severe malaria genetic association studies by augmenting phenotypic precision.
Watson JA. et al, (2021), eLife, 10
-
Bactericidal activities and post-antibiotic effects of ofloxacin and ceftriaxone against drug-resistant Salmonella enterica serovar Typhi.
Wain J. et al, (2021), The Journal of antimicrobial chemotherapy